Kaiser S, Gerok W, Häussinger D
Medizinische Universitätsklinik Freiburg, FRG.
Eur J Clin Invest. 1988 Oct;18(5):535-42. doi: 10.1111/j.1365-2362.1988.tb01053.x.
Ammonia and glutamine metabolism was studied in slices from normal, fatty and cirrhotic human livers. The liver disease was evaluated by histological examination. With respect to ammonia removal, urea and glutamine synthesis in human liver represent low and high affinity systems with k0.5(NH4+) values of 3.6 and 0.11 mM, respectively. Compared with normal control livers, cirrhotic livers showed a decreased glutamine synthesis from NH4Cl by about 80%. The same was true for urea synthesis. Conversely, flux through hepatic glutaminase was increased in cirrhosis 4-6-fold. These changes in hepatic glutamine and ammonia metabolism were observed regardless of whether reference was made to liver wet weight, DNA or protein content. Acetazolamide inhibited urea synthesis in cirrhotic liver slices by about 50%, indicating that mitochondrial carbonic anhydrase is required for urea synthesis also in cirrhosis. There was a significant correlation between the in-vitro determined capacity for urea synthesis from NH4Cl and the in-vivo determined plasma bicarbonate concentration.(ABSTRACT TRUNCATED AT 250 WORDS)
对正常、脂肪变性和肝硬化的人类肝脏切片中的氨和谷氨酰胺代谢进行了研究。通过组织学检查评估肝脏疾病。关于氨的清除,人类肝脏中的尿素和谷氨酰胺合成分别代表低亲和力和高亲和力系统,其k0.5(NH4+)值分别为3.6和0.11 mM。与正常对照肝脏相比,肝硬化肝脏从氯化铵合成谷氨酰胺的能力下降了约80%。尿素合成也是如此。相反,肝硬化时肝谷氨酰胺酶的通量增加了4至6倍。无论以肝脏湿重、DNA还是蛋白质含量为参照,均观察到肝脏谷氨酰胺和氨代谢的这些变化。乙酰唑胺抑制肝硬化肝脏切片中约50%的尿素合成,表明线粒体碳酸酐酶在肝硬化中也是尿素合成所必需的。体外测定的从氯化铵合成尿素的能力与体内测定的血浆碳酸氢盐浓度之间存在显著相关性。(摘要截短于250字)